Aprotinin but not ε-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: Randomized, double-blind, placebo-controlled study in patients receiving aprotinin and ε-aminocaproic acid

Circulation

Volumn 104, Issue SUPPL. 1, 2001, Pages

  Greilich, P E ^a   Okada, K ^a   Latham, P ^a   Kumar, R R ^a   Jessen, M E ^a  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Antifibrinolytic agents; Aprotinin; Extracorporeal circulation; Interleukins; Surgery

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART SURGERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; MIDDLE AGED; POSTOPERATIVE PERIOD; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; APROTININ; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MIDDLE AGED; POSTOPERATIVE PERIOD; SERINE PROTEINASE INHIBITORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0035908926     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
2. Perioperative factors influencing interleukin-10 release under cardiopulmonary bypass
3. Aprotinin enhances the endogenous release of interleukin-10 after cardiac operation
4. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic and pharmacologic considerations
5. Perioperative serum levels of tumor-necrosis-factor alpha (TNA-α), IL-1β, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution
6. Cytokine and compliment levels in patients undergoing cardiopulmonary bypass
7. Interleukin-10 and Interleukin-1 receptor antagonists increase during cardiac surgery
8. Aprotinin inhibits the contact, neutrophil and platelet activation systems during simulated extracorporeal perfusion
9. Reducing the post-pump syndrome by using heparin-coated circuits, steroids or aprotinin
10. High-dose aprotinin modulates the balance between proinflammatory, and anti-inflammatory responses during coronary artery bypass graft surgery
11. Circulating adhesion molecules in cardiac operations: Influence of high dose aprotinin
12. Is epsilon aminocaproic acid as effective as aprotinin effective as aprotinin in reducing bleeding with cardiac surgery
13. Corticosteriods increase blood interleukin-10 levels during cardiopulmonary bypass in men
14. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans
15. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
16. Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass
17. A randomized, controlled trail of IL-10 in humans: Inhibition of inflammatory cytokine production and immune responses
18. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
19. Influence of methylprednisolone on cytokine balance during cardiac surgery
20. Antiinflammatory cytokine profile and mortality in febrile patients
21. Synergistic immunosuppression caused by high dose methylprednisolone and cardiopulmonary bypass
22. Increased tumor necrosis factor a (TNFα), interleukin-1, and interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNFα and IL-6 levels and febrile transfusion reactions